Heat shock protein A12A activates migration of hepatocellular carcinoma cells in a monocarboxylate transporter 4–dependent manner

[1]  Qiuyue Kong,et al.  HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma , 2020, Theranostics.

[2]  Qiuyue Kong,et al.  HSPA12A attenuates lipopolysaccharide-induced liver injury through inhibiting caspase-11-mediated hepatocyte pyroptosis via PGC-1α-dependent acyloxyacyl hydrolase expression , 2020, Cell Death & Differentiation.

[3]  K. Basso,et al.  miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma , 2020, Haematologica.

[4]  Qiuyue Kong,et al.  Heat‐Shock protein A12A is a novel PCNA‐binding protein and promotes hepatocellular carcinoma growth , 2020, The FEBS journal.

[5]  N. Oksala,et al.  Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma , 2019, World journal of clinical cases.

[6]  Wei Yu,et al.  ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma , 2019, Journal of Experimental & Clinical Cancer Research.

[7]  Yibin Kang,et al.  Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. , 2019, Cancer cell.

[8]  M. Fawzy,et al.  Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study. , 2019, Clinical biochemistry.

[9]  Qiuyue Kong,et al.  HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization , 2018, Diabetes.

[10]  Kathryn A. O’Donnell,et al.  Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism , 2018, Cell reports.

[11]  Chia-Yang Hsu,et al.  Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[12]  Hsiang-Cheng Chi,et al.  Taurine up‐regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma , 2018, Hepatology.

[13]  J. Tu,et al.  HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma , 2017, Molecular Cancer.

[14]  Fang Tian,et al.  c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis , 2017, Nature Communications.

[15]  A. Saghatelian,et al.  Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis , 2017, Proceedings of the National Academy of Sciences.

[16]  Jing Yang,et al.  Epithelial–mesenchymal transition in tumor metastasis , 2016, Molecular oncology.

[17]  De-sheng Wang,et al.  Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects , 2016, World journal of gastroenterology.

[18]  B. Kuster,et al.  Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity , 2016, Nature Medicine.

[19]  W. Cong,et al.  A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma , 2016, Theranostics.

[20]  Bjorn Baselet,et al.  Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway , 2016, Cellular and Molecular Life Sciences.

[21]  Q. Zhan,et al.  Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK‐dependent signaling pathway , 2015, Molecular carcinogenesis.

[22]  Ji-Hong Liu,et al.  MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  P. Timpson,et al.  FAK signaling in human cancer as a target for therapeutics. , 2015, Pharmacology & therapeutics.

[24]  Li Xu,et al.  Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration , 2015, Journal of Cancer Research and Clinical Oncology.

[25]  K. Chijiiwa,et al.  Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[26]  John L Cleveland,et al.  Targeting lactate metabolism for cancer therapeutics. , 2013, Journal of Clinical Investigation.

[27]  W. Gong,et al.  Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70. , 2013, Oncology reports.

[28]  K. Pummer,et al.  Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma , 2013, Histopathology.

[29]  C. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[30]  Stefan Walenta,et al.  Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. , 2011, International journal of oncology.

[31]  Pierre Sonveaux,et al.  Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. , 2011, Cancer research.

[32]  M. Karin,et al.  Stressin' Sestrins take an aging fight , 2010, EMBO molecular medicine.

[33]  Yaguang Xi,et al.  Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer , 2008, Breast Cancer Research.

[34]  Gregor Rothe,et al.  Inhibitory effect of tumor cell-derived lactic acid on human T cells. , 2007, Blood.

[35]  A. Mackensen,et al.  Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. , 2006, Blood.

[36]  Jimmy R. Theriault,et al.  Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo , 2005, Cell stress & chaperones.

[37]  G. Auer,et al.  Protein expression patterns in primary carcinoma of the vagina , 2004, British Journal of Cancer.

[38]  J. Breslow,et al.  Two Hsp70 family members expressed in atherosclerotic lesions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Morimoto,et al.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death. , 2000, Journal of the National Cancer Institute.

[40]  A. Barclay,et al.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression , 2000, The EMBO journal.

[41]  E. Rofstad,et al.  High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. , 2000, Cancer research.